Feb 24, 2021 / 07:30AM GMT
Per Walday - PCI Biotech Holding ASA - CEO
Good morning, and welcome to PCI Biotech Fourth Quarter and Interim Full Year 2020 Presentation Webcast. My name is Per Walday, I'm the CEO of PCI Biotech. And I have with me also the CFO, Ronny Skuggedal.
We will start by going through the background of the company before looking at 2020 in review and then the specifics of the highlights of the fourth quarter before a more deep dive into the details on the different programs and the outlook for the coming period.
We have a webcast console here, which means that it's possible to sending questions through the webcast, and we will take those at the very end of the presentation. Before we do that, we will also open up for calls to ask questions through a call facility, and you can see on the screen now the details surrounding that call.
Okay. So without further due, let's go into the presentation. So PCI Biotech is a listed company at the Oslo Stock Exchange. We are developing a specific technology called photochemical internalisation, PCI, and we are developing that in 3 different
Q4 2020 PCI Biotech Holding ASA Earnings Call Transcript
Feb 24, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers